Related Experiment Video
Updated: Jun 18, 2026

Isolation and Characterization of Neutrophil-derived Microparticles for Functional Studies
Published on: March 2, 2018
The role of microparticles in the pathogenesis of rheumatic diseases
Christian Beyer1, David S Pisetsky
1Department for Internal Medicine 3 and Institute for Clinical Immunology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Abstract:
Microparticles (MPs) are small membrane-bound vesicles that are emerging as important elements in the pathogenesis of rheumatic diseases owing to their pleiotropic effects on thrombosis, vascular reactivity, angiogenesis and inflammation. Released from cells during activation and apoptosis, MPs carry proteins, lipids and nucleic acids, and serve as platforms for enzymatic processes in thrombosis. Furthermore, MPs can transfer cytokines, receptors, RNA and DNA to modulate the properties of target cells. As MPs appear in the blood in increased numbers during rheumatic disease, they represent novel biomarkers that can be used to assess events in otherwise inaccessible tissues. Future research will define further the pathogenetic role of MPs and explore therapeutic strategies to block their release or signaling properties.
Insights
Microparticles (MPs), small vesicles released from cells, are increasingly recognized for their role in rheumatic diseases, impacting thrombosis and inflammation. Elevated MP levels in blood may serve as novel biomarkers for assessing disease activity in affected tissues.
Area of Science:
- Rheumatology
- Vascular Biology
- Cell Biology
Background:
- Microparticles (MPs) are vesicles released during cell activation and apoptosis.
- MPs possess pleiotropic effects influencing thrombosis, vascular reactivity, angiogenesis, and inflammation.
- These vesicles carry bioactive molecules, including proteins, lipids, and nucleic acids.
Purpose of the Study:
- To highlight the emerging role of MPs in the pathogenesis of rheumatic diseases.
- To underscore the potential of MPs as biomarkers for disease assessment.
- To suggest future research directions for understanding MP function and therapeutic targeting.
Main Methods:
- Review of existing literature on microparticle function in rheumatic diseases.
- Analysis of MP composition and their transfer of molecules to target cells.
- Evaluation of MPs as potential diagnostic and prognostic indicators.
Main Results:
- MPs contribute to thrombosis, vascular dysfunction, and inflammation in rheumatic conditions.
- MPs act as platforms for enzymatic processes, particularly in thrombosis.
- Increased MP levels in circulation correlate with rheumatic disease activity.
Conclusions:
- Microparticles play a significant pathogenetic role in rheumatic diseases.
- Circulating MPs represent promising novel biomarkers for assessing disease status.
- Targeting MP release or signaling pathways may offer future therapeutic strategies.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease III: Medical Management
Chronic Inflammation: Introduction
